Overview

Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis

Status:
Unknown status
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics and safety of inhaled vancomycin in patients with cystic fibrosis.
Phase:
Phase 1
Details
Lead Sponsor:
Case Western Reserve University
Collaborators:
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation Therapeutics
Treatments:
Vancomycin